319
Participants
Start Date
August 31, 2009
Primary Completion Date
March 31, 2011
Study Completion Date
March 31, 2011
Lixisenatide (AVE0010)
Self-administered by subcutaneous injections once daily within the hour preceding breakfast.
Lixisenatide Placebo
Self-administered by subcutaneous injections once daily within the hour preceding breakfast.
Pen auto-injector
Sitagliptin
Administered orally once a day in the morning with or without food at approximately the same time each day.
Sitagliptin Placebo
Administered orally once a day in the morning with or without food at approximately the same time each day.
Metformin
Metformin to be continued at stable dose (at least 1.5 gram per day) up to Week 24.
Sanofi-Aventis Investigational Site Number 604005, Lima
Sanofi-Aventis Investigational Site Number 320004, Guatemala City
Sanofi-Aventis Investigational Site Number 036003, Sydney
Sanofi-Aventis Investigational Site Number 804001, Kiev
Sanofi-Aventis Investigational Site Number 036001, Box Hill
Sanofi-Aventis Investigational Site Number 036002, Geelong
Sanofi-Aventis Investigational Site Number 036005, Meadowbrook
Sanofi-Aventis Investigational Site Number 036006, Adelaide
Sanofi-Aventis Investigational Site Number 036004, Elizabeth Vale
Sanofi-Aventis Investigational Site Number 276002, Berlin
Sanofi-Aventis Investigational Site Number 484011, México
Sanofi-Aventis Investigational Site Number 840025, Altoona
Sanofi-Aventis Investigational Site Number 484003, Aguascalientes
Sanofi-Aventis Investigational Site Number 840007, Roswell
Sanofi-Aventis Investigational Site Number 840021, Augusta
Sanofi-Aventis Investigational Site Number 484010, Chihuahua City
Sanofi-Aventis Investigational Site Number 804004, Kyiv
Sanofi-Aventis Investigational Site Number 484009, Chihuahua City
Sanofi-Aventis Investigational Site Number 840003, Muscle Shoals
Sanofi-Aventis Investigational Site Number 840019, Montgomery
Sanofi-Aventis Investigational Site Number 840009, Brentwood
Sanofi-Aventis Investigational Site Number 484001, Pachuca
Sanofi-Aventis Investigational Site Number 484005, Pachuca
Sanofi-Aventis Investigational Site Number 840026, Perrysburg
Sanofi-Aventis Investigational Site Number 484002, Zapopan
Sanofi-Aventis Investigational Site Number 840001, Evansville
Sanofi-Aventis Investigational Site Number 840031, Clarkston
Sanofi-Aventis Investigational Site Number 804003, Chernivtsi
Sanofi-Aventis Investigational Site Number 840006, Butte
Sanofi-Aventis Investigational Site Number 840016, Chicago
Sanofi-Aventis Investigational Site Number 840018, Chicago
Sanofi-Aventis Investigational Site Number 840020, Florissant
Sanofi-Aventis Investigational Site Number 276005, Ludwigshafen
Sanofi-Aventis Investigational Site Number 840002, Baton Rouge
Sanofi-Aventis Investigational Site Number 840008, Dallas
Sanofi-Aventis Investigational Site Number 840010, San Antonio
Sanofi-Aventis Investigational Site Number 840022, Mesa
Sanofi-Aventis Investigational Site Number 840014, Paramount
Sanofi-Aventis Investigational Site Number 484006, Veracruz
Sanofi-Aventis Investigational Site Number 840027, Redlands
Sanofi-Aventis Investigational Site Number 840011, Anaheim
Sanofi-Aventis Investigational Site Number 484008, Mérida
Sanofi-Aventis Investigational Site Number 840004, Medford
Sanofi-Aventis Investigational Site Number 642009, Ploieşti
Sanofi-Aventis Investigational Site Number 643001, Saint Petersburg
Sanofi-Aventis Investigational Site Number 643003, Saint Petersburg
Sanofi-Aventis Investigational Site Number 643005, Saint Petersburg
Sanofi-Aventis Investigational Site Number 642007, Timișoara
Sanofi-Aventis Investigational Site Number 642001, Reşiţa
Sanofi-Aventis Investigational Site Number 643002, Kazan'
Sanofi-Aventis Investigational Site Number 642004, Bacau
Sanofi-Aventis Investigational Site Number 643004, Tyumen
Sanofi-Aventis Investigational Site Number 642010, Iași
Sanofi-Aventis Investigational Site Number 642005, Suceava
Sanofi-Aventis Investigational Site Number 152001, Santiago
Sanofi-Aventis Investigational Site Number 152004, Santiago
Sanofi-Aventis Investigational Site Number 152003, Santiago
Sanofi-Aventis Investigational Site Number 076005, Belém
Sanofi-Aventis Investigational Site Number 076001, Brasília
Sanofi-Aventis Investigational Site Number 076006, Caxias do Sul
Sanofi-Aventis Investigational Site Number 076003, Curitiba
Sanofi-Aventis Investigational Site Number 076002, Rio de Janeiro
Sanofi-Aventis Investigational Site Number 076004, São Paulo
Sanofi-Aventis Investigational Site Number 076007, São Paulo
Sanofi-Aventis Investigational Site Number 124004, Calgary
Sanofi-Aventis Investigational Site Number 124008, Hamilton
Sanofi-Aventis Investigational Site Number 124005, London
Sanofi-Aventis Investigational Site Number 124006, Montreal
Sanofi-Aventis Investigational Site Number 124013, Oakville
Sanofi-Aventis Investigational Site Number 124002, Saint Romuald
Sanofi-Aventis Investigational Site Number 124012, Thornhill
Sanofi-Aventis Investigational Site Number 124011, Toronto
Sanofi-Aventis Investigational Site Number 152002, Santiago
Sanofi-Aventis Investigational Site Number 152005, Santiago
Sanofi-Aventis Investigational Site Number 320005, Guatemala City
Sanofi-Aventis Investigational Site Number 320006, Guatemala City
Sanofi-Aventis Investigational Site Number 604001, Lima
Sanofi-Aventis Investigational Site Number 604002, Lima
Sanofi-Aventis Investigational Site Number 604004, Lima
Sanofi-Aventis Investigational Site Number 124003, Vancouver
Sanofi-Aventis Investigational Site Number 124007, Victoria
Sanofi-Aventis Investigational Site Number 276004, Schkeuditz
Sanofi-Aventis Investigational Site Number 320002, Guatemala City
Sanofi-Aventis Investigational Site Number 320001, Guatemala City
Sanofi-Aventis Investigational Site Number 484012, Df
Sanofi-Aventis Investigational Site Number 604003, Lima
Sanofi-Aventis Investigational Site Number 616002, Bialystok
Sanofi-Aventis Investigational Site Number 616001, Bydgoszcz
Sanofi-Aventis Investigational Site Number 616006, Warsaw
Sanofi-Aventis Investigational Site Number 616003, Wroclaw
Sanofi-Aventis Investigational Site Number 642006, Bucharest
Sanofi-Aventis Investigational Site Number 642008, Bucharest
Lead Sponsor
Sanofi
INDUSTRY